P1.07-002 G1T28, a Cyclin Dependent Kinase 4/6 Inhibitor, in Combination with Topotecan for Previously Treated Small Cell Lung Cancer: Preliminary Results
Year: 2017
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
Authors: Lowell Hart, Patrick Roberts, Renata Ferrarotto, Rodolfo Bordoni, Paul Conkling, Tejas Patil, Caio Max Rocha Lima, Taofeek Owonikoko, Steven Schuster, Robert Jotte, Robert Hoyer, Katie Stabler, Karen Makhuli, Raid Aljumaily, William Edenfield, Alexander Spira, Rajesh Malik, Geoffrey Shapiro
Institutions: G1 Therapeutics (United States), The University of Texas MD Anderson Cancer Center, Georgia Cancer Specialists, Virginia Oncology Associates, University of Colorado Anschutz, University of Colorado Denver, Emory University, University of Colorado Health, Rocky Mountain Cancer Centers, University of Oklahoma Health Sciences Center, Prisma Health, Virginia Cancer Specialists, Dana-Farber Cancer Institute
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2569113561